Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib phase 3 study in Japan
jRCT2080224992Phase 3Completed
- Start
- Dec 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
01
Overview
Phase 3 trial of baricitinib. Started Dec 2019; status: completed.
02
Drugs
baricitinib
Beyond the preview
Go deeper on jRCT2080224992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224992.